| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_081ba580f9d81648271c4872f0ef1743
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c38c7c5ba7d06ba5187ddf5f2df1dbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2f12cdc4c615d6732b3c7a97b86d4a4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-408
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-602 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate |
2007-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aee0a7b2b8e61486b4e12d0a4f7fe0d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9be41742c43231e263eb9bd297362a18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3a88ed960784c00d7f8be5da134813c |
| publicationDate |
2007-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007248629-A1 |
| titleOfInvention |
Pharmaceutical formulations for iontophoretic drug delivery |
| abstract |
The present invention provides pharmaceutical formulations suitable for iontophoresis that provide enhanced iontophoretic delivery of acyclovir (ACV) to at least one target tissue. The present invention also provides methods of treating viral infection in at least one target tissue of a patient by iontophoretically delivering a formulation of the invention to the infected target tissues of the patient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008004661-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9125911-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9549930-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7983747-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9545408-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9463180-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8532758-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010106205-A1 |
| priorityDate |
2006-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |